Weihai Lutian Pharmaceutical

Weihai Lutian Pharmaceutical is a Chinese pharmaceutical company based in Weihai, Shandong, specializing in the research, development, and manufacturing of cardiovascular and metabolic medications. As a subsidiary of Shandong Buchang Pharmaceuticals, the company is a key player in the production of chemical drugs within the group's portfolio. Its flagship products include atorvastatin calcium and amlodipine besylate, which are widely prescribed for the treatment of hyperlipidemia and hypertension. The company operates modern, GMP-certified manufacturing facilities capable of large-scale chemical synthesis and oral solid dosage production. Weihai Lutian focuses on providing high-quality, affordable generic medicines to the domestic Chinese market. Its strategic integration into Buchang Pharma has strengthened its research capabilities and market reach across China.